Drugs / Samarium (153SM)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00374751 | May 2006 → Jan 2014 | cancer, metastatic neoplasm | New York Presbyterian Brooklyn Methodist Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Samarium (153SM) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00374751 ↗ |
| Modality | Other / unclassified | “samarium (a radioactive substance)” NCT00374751 ↗ |